Table of Content

1 Preventable Vaccines Market Overview
1.1 Preventable Vaccines Product Scope
1.2 Preventable Vaccines Segment by Type
1.2.1 Global Preventable Vaccines Sales by Type (2016 & 2021 & 2027)
1.2.2 Adult Preventable Vaccines
1.2.3 Pediatric Preventable Vaccines
1.3 Preventable Vaccines Segment by Application
1.3.1 Global Preventable Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Bacterial Diseases
1.3.3 Virus Diseases
1.4 Preventable Vaccines Market Estimates and Forecasts (2016-2027)
1.4.1 Global Preventable Vaccines Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Preventable Vaccines Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Preventable Vaccines Price Trends (2016-2027)

2 Preventable Vaccines Estimates and Forecasts by Region
2.1 Global Preventable Vaccines Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Preventable Vaccines Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Preventable Vaccines Sales Market Share by Region (2016-2021)
2.2.2 Global Preventable Vaccines Revenue Market Share by Region (2016-2021)
2.3 Global Preventable Vaccines Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Preventable Vaccines Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Preventable Vaccines Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Preventable Vaccines Estimates and Projections (2016-2027)
2.4.2 Europe Preventable Vaccines Estimates and Projections (2016-2027)
2.4.3 China Preventable Vaccines Estimates and Projections (2016-2027)
2.4.4 Japan Preventable Vaccines Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Preventable Vaccines Estimates and Projections (2016-2027)
2.4.6 India Preventable Vaccines Estimates and Projections (2016-2027)

3 Global Preventable Vaccines Competition Landscape by Players
3.1 Global Top Preventable Vaccines Players by Sales (2016-2021)
3.2 Global Top Preventable Vaccines Players by Revenue (2016-2021)
3.3 Global Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Preventable Vaccines as of 2020)
3.4 Global Preventable Vaccines Average Price by Company (2016-2021)
3.5 Manufacturers Preventable Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Preventable Vaccines Market Size by Type
4.1 Global Preventable Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Preventable Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Preventable Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Global Preventable Vaccines Price by Type (2016-2021)
4.2 Global Preventable Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Preventable Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Preventable Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Global Preventable Vaccines Price Forecast by Type (2022-2027)

5 Global Preventable Vaccines Market Size by Application
5.1 Global Preventable Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Preventable Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Preventable Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Global Preventable Vaccines Price by Application (2016-2021)
5.2 Global Preventable Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Preventable Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Preventable Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Preventable Vaccines Price Forecast by Application (2022-2027)

6 North America Preventable Vaccines Market Facts & Figures
6.1 North America Preventable Vaccines Sales by Company
6.1.1 North America Preventable Vaccines Sales by Company (2016-2021)
6.1.2 North America Preventable Vaccines Revenue by Company (2016-2021)
6.2 North America Preventable Vaccines Sales Breakdown by Type
6.2.1 North America Preventable Vaccines Sales Breakdown by Type (2016-2021)
6.2.2 North America Preventable Vaccines Sales Breakdown by Type (2022-2027)
6.3 North America Preventable Vaccines Sales Breakdown by Application
6.3.1 North America Preventable Vaccines Sales Breakdown by Application (2016-2021)
6.3.2 North America Preventable Vaccines Sales Breakdown by Application (2022-2027)

7 Europe Preventable Vaccines Market Facts & Figures
7.1 Europe Preventable Vaccines Sales by Company
7.1.1 Europe Preventable Vaccines Sales by Company (2016-2021)
7.1.2 Europe Preventable Vaccines Revenue by Company (2016-2021)
7.2 Europe Preventable Vaccines Sales Breakdown by Type
7.2.1 Europe Preventable Vaccines Sales Breakdown by Type (2016-2021)
7.2.2 Europe Preventable Vaccines Sales Breakdown by Type (2022-2027)
7.3 Europe Preventable Vaccines Sales Breakdown by Application
7.3.1 Europe 154 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 154 Sales Breakdown by Application (2022-2027)

8 China Preventable Vaccines Market Facts & Figures
8.1 China Preventable Vaccines Sales by Company
8.1.1 China Preventable Vaccines Sales by Company (2016-2021)
8.1.2 China Preventable Vaccines Revenue by Company (2016-2021)
8.2 China Preventable Vaccines Sales Breakdown by Type
8.2.1 China Preventable Vaccines Sales Breakdown by Type (2016-2021)
8.2.2 China Preventable Vaccines Sales Breakdown by Type (2022-2027)
8.3 China Preventable Vaccines Sales Breakdown by Application
8.3.1 China 171 Sales Breakdown by Application (2016-2021)
8.3.2 China 171 Sales Breakdown by Application (2022-2027)

9 Japan Preventable Vaccines Market Facts & Figures
9.1 Japan Preventable Vaccines Sales by Company
9.1.1 Japan Preventable Vaccines Sales by Company (2016-2021)
9.1.2 Japan Preventable Vaccines Revenue by Company (2016-2021)
9.2 Japan Preventable Vaccines Sales Breakdown by Type
9.2.1 Japan Preventable Vaccines Sales Breakdown by Type (2016-2021)
9.2.2 Japan Preventable Vaccines Sales Breakdown by Type (2022-2027)
9.3 Japan Preventable Vaccines Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Preventable Vaccines Market Facts & Figures
10.1 Southeast Asia Preventable Vaccines Sales by Company
10.1.1 Southeast Asia Preventable Vaccines Sales by Company (2016-2021)
10.1.2 Southeast Asia Preventable Vaccines Revenue by Company (2016-2021)
10.2 Southeast Asia Preventable Vaccines Sales Breakdown by Type
10.2.1 Southeast Asia Preventable Vaccines Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Preventable Vaccines Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Preventable Vaccines Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Preventable Vaccines Market Facts & Figures
11.1 India Preventable Vaccines Sales by Company
11.1.1 India Preventable Vaccines Sales by Company (2016-2021)
11.1.2 India Preventable Vaccines Revenue by Company (2016-2021)
11.2 India Preventable Vaccines Sales Breakdown by Type
11.2.1 India Preventable Vaccines Sales Breakdown by Type (2016-2021)
11.2.2 India Preventable Vaccines Sales Breakdown by Type (2022-2027)
11.3 India Preventable Vaccines Sales Breakdown by Application
11.3.1 India Preventable Vaccines Sales Breakdown by Application (2016-2021)
11.3.2 India Preventable Vaccines Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Preventable Vaccines Business
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Corporation Information
12.1.2 GlaxoSmithKline Business Overview
12.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GlaxoSmithKline Preventable Vaccines Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Preventable Vaccines Products Offered
12.2.5 Merck Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Preventable Vaccines Products Offered
12.3.5 Novartis Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Preventable Vaccines Products Offered
12.4.5 Pfizer Recent Development
12.5 Sanofi
12.5.1 Sanofi Corporation Information
12.5.2 Sanofi Business Overview
12.5.3 Sanofi Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sanofi Preventable Vaccines Products Offered
12.5.5 Sanofi Recent Development
12.6 Takeda Pharmaceutical
12.6.1 Takeda Pharmaceutical Corporation Information
12.6.2 Takeda Pharmaceutical Business Overview
12.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Takeda Pharmaceutical Preventable Vaccines Products Offered
12.6.5 Takeda Pharmaceutical Recent Development
12.7 Abbott
12.7.1 Abbott Corporation Information
12.7.2 Abbott Business Overview
12.7.3 Abbott Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Abbott Preventable Vaccines Products Offered
12.7.5 Abbott Recent Development
12.8 Roche
12.8.1 Roche Corporation Information
12.8.2 Roche Business Overview
12.8.3 Roche Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Roche Preventable Vaccines Products Offered
12.8.5 Roche Recent Development
12.9 AstraZeneca
12.9.1 AstraZeneca Corporation Information
12.9.2 AstraZeneca Business Overview
12.9.3 AstraZeneca Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 AstraZeneca Preventable Vaccines Products Offered
12.9.5 AstraZeneca Recent Development
12.10 Mitsubishi Tanabe Pharma
12.10.1 Mitsubishi Tanabe Pharma Corporation Information
12.10.2 Mitsubishi Tanabe Pharma Business Overview
12.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Mitsubishi Tanabe Pharma Preventable Vaccines Products Offered
12.10.5 Mitsubishi Tanabe Pharma Recent Development
12.11 Lupin
12.11.1 Lupin Corporation Information
12.11.2 Lupin Business Overview
12.11.3 Lupin Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Lupin Preventable Vaccines Products Offered
12.11.5 Lupin Recent Development
12.12 Serum Institute of India
12.12.1 Serum Institute of India Corporation Information
12.12.2 Serum Institute of India Business Overview
12.12.3 Serum Institute of India Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Serum Institute of India Preventable Vaccines Products Offered
12.12.5 Serum Institute of India Recent Development
12.13 LG Life Sciences
12.13.1 LG Life Sciences Corporation Information
12.13.2 LG Life Sciences Business Overview
12.13.3 LG Life Sciences Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.13.4 LG Life Sciences Preventable Vaccines Products Offered
12.13.5 LG Life Sciences Recent Development
12.14 S K Chemicals
12.14.1 S K Chemicals Corporation Information
12.14.2 S K Chemicals Business Overview
12.14.3 S K Chemicals Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.14.4 S K Chemicals Preventable Vaccines Products Offered
12.14.5 S K Chemicals Recent Development
12.15 Shenzhen Kangtai Biological Products
12.15.1 Shenzhen Kangtai Biological Products Corporation Information
12.15.2 Shenzhen Kangtai Biological Products Business Overview
12.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Shenzhen Kangtai Biological Products Preventable Vaccines Products Offered
12.15.5 Shenzhen Kangtai Biological Products Recent Development
12.16 Sinovac Biotech
12.16.1 Sinovac Biotech Corporation Information
12.16.2 Sinovac Biotech Business Overview
12.16.3 Sinovac Biotech Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Sinovac Biotech Preventable Vaccines Products Offered
12.16.5 Sinovac Biotech Recent Development
12.17 Janssen Pharmaceuticals
12.17.1 Janssen Pharmaceuticals Corporation Information
12.17.2 Janssen Pharmaceuticals Business Overview
12.17.3 Janssen Pharmaceuticals Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Janssen Pharmaceuticals Preventable Vaccines Products Offered
12.17.5 Janssen Pharmaceuticals Recent Development
12.18 Crucell
12.18.1 Crucell Corporation Information
12.18.2 Crucell Business Overview
12.18.3 Crucell Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Crucell Preventable Vaccines Products Offered
12.18.5 Crucell Recent Development
12.19 Bavarian Nordic
12.19.1 Bavarian Nordic Corporation Information
12.19.2 Bavarian Nordic Business Overview
12.19.3 Bavarian Nordic Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Bavarian Nordic Preventable Vaccines Products Offered
12.19.5 Bavarian Nordic Recent Development
12.20 Baxter
12.20.1 Baxter Corporation Information
12.20.2 Baxter Business Overview
12.20.3 Baxter Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Baxter Preventable Vaccines Products Offered
12.20.5 Baxter Recent Development
12.21 Bharat Biotech
12.21.1 Bharat Biotech Corporation Information
12.21.2 Bharat Biotech Business Overview
12.21.3 Bharat Biotech Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Bharat Biotech Preventable Vaccines Products Offered
12.21.5 Bharat Biotech Recent Development
12.22 Dynavax
12.22.1 Dynavax Corporation Information
12.22.2 Dynavax Business Overview
12.22.3 Dynavax Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Dynavax Preventable Vaccines Products Offered
12.22.5 Dynavax Recent Development
12.23 Bausch Health
12.23.1 Bausch Health Corporation Information
12.23.2 Bausch Health Business Overview
12.23.3 Bausch Health Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Bausch Health Preventable Vaccines Products Offered
12.23.5 Bausch Health Recent Development
12.24 Protein Sciences
12.24.1 Protein Sciences Corporation Information
12.24.2 Protein Sciences Business Overview
12.24.3 Protein Sciences Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Protein Sciences Preventable Vaccines Products Offered
12.24.5 Protein Sciences Recent Development
12.25 Panacea Biotec
12.25.1 Panacea Biotec Corporation Information
12.25.2 Panacea Biotec Business Overview
12.25.3 Panacea Biotec Preventable Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.25.4 Panacea Biotec Preventable Vaccines Products Offered
12.25.5 Panacea Biotec Recent Development

13 Preventable Vaccines Manufacturing Cost Analysis
13.1 Preventable Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Preventable Vaccines
13.4 Preventable Vaccines Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Preventable Vaccines Distributors List
14.3 Preventable Vaccines Customers

15 Market Dynamics
15.1 Preventable Vaccines Market Trends
15.2 Preventable Vaccines Drivers
15.3 Preventable Vaccines Market Challenges
15.4 Preventable Vaccines Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Preventable Vaccines Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Preventable Vaccines Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Preventable Vaccines Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Preventable Vaccines Sales (K Units) by Region (2016-2021)
Table 5. Global Preventable Vaccines Sales Market Share by Region (2016-2021)
Table 6. Global Preventable Vaccines Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Preventable Vaccines Revenue Share by Region (2016-2021)
Table 8. Global Preventable Vaccines Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Preventable Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Preventable Vaccines Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Preventable Vaccines Revenue Share Forecast by Region (2022-2027)
Table 12. Global Preventable Vaccines Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Preventable Vaccines Sales Share by Company (2016-2021)
Table 14. Global Preventable Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Preventable Vaccines Revenue Share by Company (2016-2021)
Table 16. Global Preventable Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preventable Vaccines as of 2020)
Table 17. Global Preventable Vaccines Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Preventable Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers Preventable Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Preventable Vaccines Sales (K Units) by Type (2016-2021)
Table 22. Global Preventable Vaccines Sales Share by Type (2016-2021)
Table 23. Global Preventable Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Preventable Vaccines Price (USD/Unit) by Type (2016-2021)
Table 25. Global Preventable Vaccines Sales Share by Type (2022-2027)
Table 26. Global Preventable Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Preventable Vaccines Revenue Share by Type (2022-2027)
Table 28. Global Preventable Vaccines Price (USD/Unit) by Type (2022-2027)
Table 29. Global Preventable Vaccines Sales (K Units) by Application (2016-2021)
Table 30. Global Preventable Vaccines Sales Share by Application (2016-2021)
Table 31. Global Preventable Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Preventable Vaccines Price (USD/Unit) by Application (2016-2021)
Table 33. Global Preventable Vaccines Sales (K Units) by Application (2022-2027)
Table 34. Global Preventable Vaccines Sales Share by Application (2022-2027)
Table 35. Global Preventable Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Preventable Vaccines Revenue Share by Application (2022-2027)
Table 37. Global Preventable Vaccines Price (USD/Unit) by Application (2022-2027)
Table 38. North America Preventable Vaccines Sales (K Units) by Company (2016-2021)
Table 39. North America Preventable Vaccines Sales Market Share by Company (2016-2021)
Table 40. North America Preventable Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Preventable Vaccines Revenue Market Share by Company (2016-2021)
Table 42. North America Preventable Vaccines Sales by Type (2016-2021) & (K Units)
Table 43. North America Preventable Vaccines Sales Market Share by Type (2016-2021)
Table 44. North America Preventable Vaccines Sales by Type (2022-2027) & (K Units)
Table 45. North America Preventable Vaccines Sales Market Share by Type (2022-2027)
Table 46. North America Preventable Vaccines Sales by Application (2016-2021) & (K Units)
Table 47. North America Preventable Vaccines Sales Market Share by Application (2016-2021)
Table 48. North America Preventable Vaccines Sales by Application (2022-2027) & (K Units)
Table 49. North America Preventable Vaccines Sales Market Share by Application (2022-2027)
Table 50. Europe Preventable Vaccines Sales (K Units) by Company (2016-2021)
Table 51. Europe Preventable Vaccines Sales Market Share by Company (2016-2021)
Table 52. Europe Preventable Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Preventable Vaccines Revenue Market Share by Company (2016-2021)
Table 54. Europe Preventable Vaccines Sales by Type (2016-2021) & (K Units)
Table 55. Europe Preventable Vaccines Sales Market Share by Type (2016-2021)
Table 56. Europe Preventable Vaccines Sales by Type (2022-2027) & (K Units)
Table 57. Europe Preventable Vaccines Sales Market Share by Type (2022-2027)
Table 58. Europe Preventable Vaccines Sales by Application (2016-2021) & (K Units)
Table 59. Europe Preventable Vaccines Sales Market Share by Application (2016-2021)
Table 60. Europe Preventable Vaccines Sales by Application (2022-2027) & (K Units)
Table 61. Europe Preventable Vaccines Sales Market Share by Application (2022-2027)
Table 62. China Preventable Vaccines Sales (K Units) by Company (2016-2021)
Table 63. China Preventable Vaccines Sales Market Share by Company (2016-2021)
Table 64. China Preventable Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Preventable Vaccines Revenue Market Share by Company (2016-2021)
Table 66. China Preventable Vaccines Sales by Type (2016-2021) & (K Units)
Table 67. China Preventable Vaccines Sales Market Share by Type (2016-2021)
Table 68. China Preventable Vaccines Sales by Type (2022-2027) & (K Units)
Table 69. China Preventable Vaccines Sales Market Share by Type (2022-2027)
Table 70. China Preventable Vaccines Sales by Application (2016-2021) & (K Units)
Table 71. China Preventable Vaccines Sales Market Share by Application (2016-2021)
Table 72. China Preventable Vaccines Sales by Application (2022-2027) & (K Units)
Table 73. China Preventable Vaccines Sales Market Share by Application (2022-2027)
Table 74. Japan Preventable Vaccines Sales (K Units) by Company (2016-2021)
Table 75. Japan Preventable Vaccines Sales Market Share by Company (2016-2021)
Table 76. Japan Preventable Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Preventable Vaccines Revenue Market Share by Company (2016-2021)
Table 78. Japan Preventable Vaccines Sales by Type (2016-2021) & (K Units)
Table 79. Japan Preventable Vaccines Sales Market Share by Type (2016-2021)
Table 80. Japan Preventable Vaccines Sales by Type (2022-2027) & (K Units)
Table 81. Japan Preventable Vaccines Sales Market Share by Type (2022-2027)
Table 82. Japan Preventable Vaccines Sales by Application (2016-2021) & (K Units)
Table 83. Japan Preventable Vaccines Sales Market Share by Application (2016-2021)
Table 84. Japan Preventable Vaccines Sales by Application (2022-2027) & (K Units)
Table 85. Japan Preventable Vaccines Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Preventable Vaccines Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Preventable Vaccines Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Preventable Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Preventable Vaccines Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Preventable Vaccines Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Preventable Vaccines Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Preventable Vaccines Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Preventable Vaccines Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Preventable Vaccines Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Preventable Vaccines Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Preventable Vaccines Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Preventable Vaccines Sales Market Share by Application (2022-2027)
Table 98. India Preventable Vaccines Sales (K Units) by Company (2016-2021)
Table 99. India Preventable Vaccines Sales Market Share by Company (2016-2021)
Table 100. India Preventable Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Preventable Vaccines Revenue Market Share by Company (2016-2021)
Table 102. India Preventable Vaccines Sales by Type (2016-2021) & (K Units)
Table 103. India Preventable Vaccines Sales Market Share by Type (2016-2021)
Table 104. India Preventable Vaccines Sales by Type (2022-2027) & (K Units)
Table 105. India Preventable Vaccines Sales Market Share by Type (2022-2027)
Table 106. India Preventable Vaccines Sales by Application (2016-2021) & (K Units)
Table 107. India Preventable Vaccines Sales Market Share by Application (2016-2021)
Table 108. India Preventable Vaccines Sales by Application (2022-2027) & (K Units)
Table 109. India Preventable Vaccines Sales Market Share by Application (2022-2027)
Table 110. GlaxoSmithKline Corporation Information
Table 111. GlaxoSmithKline Description and Business Overview
Table 112. GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. GlaxoSmithKline Preventable Vaccines Product
Table 114. GlaxoSmithKline Recent Development
Table 115. Merck Corporation Information
Table 116. Merck Description and Business Overview
Table 117. Merck Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Merck Preventable Vaccines Product
Table 119. Merck Recent Development
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Novartis Preventable Vaccines Product
Table 124. Novartis Recent Development
Table 125. Pfizer Corporation Information
Table 126. Pfizer Description and Business Overview
Table 127. Pfizer Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Pfizer Preventable Vaccines Product
Table 129. Pfizer Recent Development
Table 130. Sanofi Corporation Information
Table 131. Sanofi Description and Business Overview
Table 132. Sanofi Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Sanofi Preventable Vaccines Product
Table 134. Sanofi Recent Development
Table 135. Takeda Pharmaceutical Corporation Information
Table 136. Takeda Pharmaceutical Description and Business Overview
Table 137. Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Takeda Pharmaceutical Preventable Vaccines Product
Table 139. Takeda Pharmaceutical Recent Development
Table 140. Abbott Corporation Information
Table 141. Abbott Description and Business Overview
Table 142. Abbott Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Abbott Preventable Vaccines Product
Table 144. Abbott Recent Development
Table 145. Roche Corporation Information
Table 146. Roche Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Roche Description and Business Overview
Table 148. Roche Preventable Vaccines Product
Table 149. Roche Recent Development
Table 150. AstraZeneca Corporation Information
Table 151. AstraZeneca Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. AstraZeneca Description and Business Overview
Table 153. AstraZeneca Preventable Vaccines Product
Table 154. AstraZeneca Recent Development
Table 155. Mitsubishi Tanabe Pharma Corporation Information
Table 156. Mitsubishi Tanabe Pharma Description and Business Overview
Table 157. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Mitsubishi Tanabe Pharma Preventable Vaccines Product
Table 159. Mitsubishi Tanabe Pharma Recent Development
Table 160. Lupin Corporation Information
Table 161. Lupin Description and Business Overview
Table 162. Lupin Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Lupin Preventable Vaccines Product
Table 164. Lupin Recent Development
Table 165. Serum Institute of India Corporation Information
Table 166. Serum Institute of India Description and Business Overview
Table 167. Serum Institute of India Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Serum Institute of India Preventable Vaccines Product
Table 169. Serum Institute of India Recent Development
Table 170. LG Life Sciences Corporation Information
Table 171. LG Life Sciences Description and Business Overview
Table 172. LG Life Sciences Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 173. LG Life Sciences Preventable Vaccines Product
Table 174. LG Life Sciences Recent Development
Table 175. S K Chemicals Corporation Information
Table 176. S K Chemicals Description and Business Overview
Table 177. S K Chemicals Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 178. S K Chemicals Preventable Vaccines Product
Table 179. S K Chemicals Recent Development
Table 180. Shenzhen Kangtai Biological Products Corporation Information
Table 181. Shenzhen Kangtai Biological Products Description and Business Overview
Table 182. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 183. Shenzhen Kangtai Biological Products Preventable Vaccines Product
Table 184. Shenzhen Kangtai Biological Products Recent Development
Table 185. Sinovac Biotech Corporation Information
Table 186. Sinovac Biotech Description and Business Overview
Table 187. Sinovac Biotech Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 188. Sinovac Biotech Preventable Vaccines Product
Table 189. Sinovac Biotech Recent Development
Table 190. Janssen Pharmaceuticals Corporation Information
Table 191. Janssen Pharmaceuticals Description and Business Overview
Table 192. Janssen Pharmaceuticals Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 193. Janssen Pharmaceuticals Preventable Vaccines Product
Table 194. Janssen Pharmaceuticals Recent Development
Table 195. Crucell Corporation Information
Table 196. Crucell Description and Business Overview
Table 197. Crucell Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 198. Crucell Preventable Vaccines Product
Table 199. Crucell Recent Development
Table 200. Bavarian Nordic Corporation Information
Table 201. Bavarian Nordic Description and Business Overview
Table 202. Bavarian Nordic Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 203. Bavarian Nordic Preventable Vaccines Product
Table 204. Bavarian Nordic Recent Development
Table 205. Baxter Corporation Information
Table 206. Baxter Description and Business Overview
Table 207. Baxter Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 208. Baxter Preventable Vaccines Product
Table 209. Baxter Recent Development
Table 210. Bharat Biotech Corporation Information
Table 211. Bharat Biotech Description and Business Overview
Table 212. Bharat Biotech Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 213. Bharat Biotech Preventable Vaccines Product
Table 214. Bharat Biotech Recent Development
Table 215. Dynavax Corporation Information
Table 216. Dynavax Description and Business Overview
Table 217. Dynavax Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 218. Dynavax Preventable Vaccines Product
Table 219. Dynavax Recent Development
Table 220. Bausch Health Corporation Information
Table 221. Bausch Health Description and Business Overview
Table 222. Bausch Health Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 223. Bausch Health Preventable Vaccines Product
Table 224. Bausch Health Recent Development
Table 225. Protein Sciences Corporation Information
Table 226. Protein Sciences Description and Business Overview
Table 227. Protein Sciences Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 228. Protein Sciences Preventable Vaccines Product
Table 229. Protein Sciences Recent Development
Table 230. Panacea Biotec Corporation Information
Table 231. Panacea Biotec Description and Business Overview
Table 232. Panacea Biotec Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 233. Panacea Biotec Preventable Vaccines Product
Table 234. Panacea Biotec Recent Development
Table 235. Production Base and Market Concentration Rate of Raw Material
Table 236. Key Suppliers of Raw Materials
Table 237. Preventable Vaccines Distributors List
Table 238. Preventable Vaccines Customers List
Table 239. Preventable Vaccines Market Trends
Table 240. Preventable Vaccines Market Drivers
Table 241. Preventable Vaccines Market Challenges
Table 242. Preventable Vaccines Market Restraints
Table 243. Research Programs/Design for This Report
Table 244. Key Data Information from Secondary Sources
Table 245. Key Data Information from Primary Sources
List of Figures
Figure 1. Preventable Vaccines Product Picture
Figure 2. Global Preventable Vaccines Sales Market Share by Type in 2021 & 2027
Figure 3. Adult Preventable Vaccines Product Picture
Figure 4. Pediatric Preventable Vaccines Product Picture
Figure 5. Global Preventable Vaccines Sales Market Share by Application in 2021 & 2027
Figure 6. Bacterial Diseases Examples
Figure 7. Virus Diseases Examples
Figure 8. Global Preventable Vaccines Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Preventable Vaccines Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Preventable Vaccines Sales (K Units) Growth Rate (2016-2027)
Figure 11. Global Preventable Vaccines Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 12. Global Preventable Vaccines Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Preventable Vaccines Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Preventable Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Preventable Vaccines Sales (K Units) Growth Rate (2016-2027)
Figure 16. Europe Preventable Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Preventable Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Preventable Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Preventable Vaccines Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Preventable Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Preventable Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Preventable Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Preventable Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Preventable Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Preventable Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Preventable Vaccines Players Market Share by Revenue in Preventable Vaccines: 2016 & 2020
Figure 27. Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Preventable Vaccines Revenue Share by Type (2016-2021)
Figure 29. Global Preventable Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Preventable Vaccines Revenue Share by Application (2016-2021)
Figure 31. Global Preventable Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Preventable Vaccines Sales Market Share by Type in 2020
Figure 33. North America Preventable Vaccines Sales Market Share by Application in 2020
Figure 34. Europe Preventable Vaccines Sales Market Share by Type in 2020
Figure 35. Europe Preventable Vaccines Sales Market Share by Application in 2020
Figure 36. China Preventable Vaccines Sales Market Share by Type in 2020
Figure 37. China Preventable Vaccines Sales Market Share by Application in 2020
Figure 38. Japan Preventable Vaccines Sales Market Share by Type in 2020
Figure 39. Japan Preventable Vaccines Sales Market Share by Application in 2020
Figure 40. Southeast Asia Preventable Vaccines Sales Market Share by Type in 2020
Figure 41. Southeast Asia Preventable Vaccines Sales Market Share by Application in 2020
Figure 42. India Preventable Vaccines Sales Market Share by Type in 2020
Figure 43. India Preventable Vaccines Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Preventable Vaccines
Figure 46. Manufacturing Process Analysis of Preventable Vaccines
Figure 47. Preventable Vaccines Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed